Valuation: TAUNS Laboratories,Inc.

Market Cap 4.99TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.96TCr 44Cr 294.65Cr 116.22Cr 1.45TCr 115.48Cr 112.92Cr P/E 2025
8.67x
P/E 2026 * 9.41x
Enterprise Value 5.67TCr 35Cr 31Cr 28Cr 26Cr 49Cr 3.36TCr 50Cr 334.99Cr 132.14Cr 1.64TCr 131.29Cr 128.38Cr EV / Sales 2025
3.23x
EV / Sales 2026 * 3.92x
Free-Float
29.82%
Yield 2025
5.2%
Yield 2026 * 7.54%
1 day+0.43%
1 week-0.43%
Current month-0.85%
1 month-3.51%
3 months-5.84%
6 months-8.59%
Current year-8.06%
1 week 464
Extreme 464
473
1 month 463
Extreme 463
492
Current year 463
Extreme 463
568
1 year 463
Extreme 463
603
3 years 401
Extreme 401
733
5 years 401
Extreme 401
733
10 years 401
Extreme 401
733
Manager TitleAgeSince
Chief Executive Officer 51 01/05/2014
Director of Finance/CFO 66 01/11/2018
Corporate Officer/Principal 39 01/07/2022
Director TitleAgeSince
Director/Board Member 62 01/09/2020
Director/Board Member 53 01/04/2016
Director/Board Member 39 01/09/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%-0.43%-13.65% - 31Cr
+1.08%-1.72%+221.70%+317.82% 2.1TCr
-0.92%-0.50%-41.30%-25.27% 952.8Cr
-2.87%-1.01%+23.25%+18.91% 686.15Cr
+9.62%+21.04%+267.20%-21.19% 530.3Cr
-1.52%+10.39%-20.51%-31.08% 512.42Cr
-0.64%-2.98%-38.85% - 482.25Cr
0.00%+4.00%-23.02%-25.71% 419.85Cr
+10.01%+1.92%+64.64%+76.27% 342.43Cr
+2.15%+4.49%-16.13%-41.29% 262.94Cr
Average +1.73%+0.81%+42.33%+33.56% 632.01Cr
Weighted average by Cap. +1.18%-0.81%+89.00%+109.13%

Financials

2025 2026 *
Net sales 1.91TCr 12Cr 10Cr 9.51Cr 8.77Cr 17Cr 1.13TCr 17Cr 112.59Cr 44Cr 552.15Cr 44Cr 43Cr 1.48TCr 9.09Cr 7.96Cr 7.36Cr 6.79Cr 13Cr 874.85Cr 13Cr 87Cr 34Cr 427.46Cr 34Cr 33Cr
Net income 649.96Cr 4.01Cr 3.51Cr 3.24Cr 2.99Cr 5.63Cr 385.35Cr 5.75Cr 38Cr 15Cr 188.28Cr 15Cr 15Cr 520.13Cr 3.21Cr 2.81Cr 2.59Cr 2.39Cr 4.5Cr 308.38Cr 4.6Cr 31Cr 12Cr 150.68Cr 12Cr 12Cr
Net Debt 682.93Cr 4.21Cr 3.69Cr 3.41Cr 3.14Cr 5.91Cr 404.89Cr 6.04Cr 40Cr 16Cr 197.83Cr 16Cr 15Cr 799.4Cr 4.93Cr 4.31Cr 3.99Cr 3.68Cr 6.92Cr 473.95Cr 7.07Cr 47Cr 19Cr 231.57Cr 19Cr 18Cr
Logo TAUNS Laboratories,Inc.
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Employees
218
Date Price Change Volume
14/26/14 JP¥468.00 +0.43% 1,97,300
13/26/13 JP¥466.00 -0.64% 2,26,600
10/26/10 JP¥469.00 +0.86% 3,14,400
09/26/09 JP¥465.00 -0.43% 2,37,200
08/26/08 JP¥467.00 -0.64% 2,00,200
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
468.00JPY
Average target price
420.00JPY
Spread / Average Target
-10.26%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 197A Stock